Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Dec 12:10:1-5.
doi: 10.1016/j.nmni.2015.11.013. eCollection 2016 Mar.

Distribution of innate efflux-mediated aminoglycoside resistance among different Achromobacter species

Affiliations

Distribution of innate efflux-mediated aminoglycoside resistance among different Achromobacter species

J Bador et al. New Microbes New Infect. .

Abstract

Achromobacter spp. are emerging respiratory pathogens in cystic fibrosis patients. Since 2013 the genus Achromobacter includes 15 species for which innate antibiotic resistance is unknown. Previously the AxyXY-OprZ efflux system has been described to confer aminoglycoside (AG) resistance in A. xylosoxidans. Nevertheless, some Achromobacter spp. strains are susceptible to AG. This study including 49 Achromobacter isolates reveals that AG resistance is correlated with different Achromobacter spp. It is noteworthy that the axyXY-oprZ operon is detected only in AG-resistant species, including the most frequently encountered in cystic fibrosis patients: A. xylosoxidans, A. ruhlandii, A. dolens and A. insuavis.

Keywords: Achromobacter; AxyXY-OprZ; aminoglycoside resistance; cystic fibrosis; nrdA; selection pressure.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
ACH-CF-583 nrdA sequence alignment with its closest match (genogroup 19) in Achromobacter PubMLST database. Query: ACH-CF-583; Ref: closest match in database.
Fig. 2
Fig. 2
Neighbour-joining dendrogram based on nrdA sequence. Numbers at nodes indicate bootstrap values. Scale bar indicates number of substitutions per site. AG-resistant (AG-R) isolates are in upper box; AG-susceptible (AG-S) isolates are in boxes ‘cluster 1’ and ‘cluster 2.’ AG resistance was not determined for the LMG strains.

References

    1. Amoureux L., Bador J., Siebor E., Taillefumier N., Fanton A., Neuwirth C. Epidemiology and resistance of Achromobacter xylosoxidans from cystic fibrosis patients in Dijon, Burgundy: first French data. J Cyst Fibros. 2013;12:170–176. - PubMed
    1. Emerson J., McNamara S., Buccat A.M., Worrell K., Burns J.L. Changes in cystic fibrosis sputum microbiology in the United States between 1995 and 2008. Pediatr Pulmonol. 2010;45:363–370. - PubMed
    1. Yabuuchi E., Oyama A. Achromobacter xylosoxidans n. sp. from human ear discharge. Jpn J Microbiol. 1971;15:477–481. - PubMed
    1. Yabuuchi E., Kawamura Y., Kosako Y., Ezaki T. Emendation of genus Achromobacter and Achromobacter xylosoxidans (Yabuuchi and Yano) and proposal of Achromobacter ruhlandii (Packer and Vishniac) comb. nov., Achromobacter piechaudii (Kiredjian et al.) comb. nov., and Achromobacter xylosoxidans subsp. denitrificans (Rüger and Tan) comb. nov. Microbiol Immunol. 1998;42:429–438. - PubMed
    1. Coenye T., Vancanneyt M., Cnockaert M.C., Falsen E., Swings J., Vandamme P. Kerstersia gyiorum gen. nov., sp. nov., a novel Alcaligenes faecalis–like organism isolated from human clinical samples, and reclassification of Alcaligenes denitrificans Rüger and Tan 1983 as Achromobacter denitrificans comb. nov. Int J Syst Evol Microbiol. 2003;53:1825–1831. - PubMed

LinkOut - more resources